LSI is actively seeking partnerships as well as customers for utilizing our sugar-lipid technology/platform by suitable arrangements. The company is focused on the development of next-generation proprietary formulations of sterile injectable drugs as well as other liquid or solid dosage forms, principally aimed at the domains of anesthesiology (solution product of injection-site-pain free combo of propofol-lidocaine), oncology (both alcohol and solvent free taxane etc) and infectious disease. The firm has developed a revolutionary approach (Sugar-lipid-polymer) to the formulation of poor water-soluble drugs, which enables the creation of products with greater stability, superior shelf life, improved ease of manufacturing and enhanced safety. Especially our alcohol- and solvent-free oncology injectable formula is used to provide an affordable and effective (i.e., taxane-mAb) combo chemotherapy.
Benefit of Sugar-Lipid Drug Delivery:
As one of the examples: reformulation of propofol-lidocaine with the sugar-lipid polymer offers benefits to patients that require anesthetics prior to and during medical procedures. Our product benefits over competitors’ products (e.g. Diprivan and 1% Propofol Injectable Emulsion) are:
- Lower manufacturing costs
- Improved patient care through reduction of side effects, such as pain on injection
- Decreases in risks associated with emulsion dosage forms
- Increase in profitability to hospitals and clinics
- Sustained competitive advantages through intellectual property protection
Our intellectual properties, technologies and product differentiations will allow LipoSeuticals to capture market share and charge a price commensurate to the brand. These benefits from the sugar-lipid technology can be shared with potential collaborators to match their product development needs
Custom Formulation
We are always open to partnerships and new business avenues and opportunities. If you will need drug delivery support and want to collaborate with us for product formulation of poorly water soluble compounds, kindly get in touch with us and we will try our best to leverage both of our skills and expertise to come up with a solution for your new products. LSI Scientists will work on contracted assignments with commercial available Generally Recognized as Safe (GRAS) excipients and our proprietary pure pegylated sugar lipids for clients on a service-for-fee basis.
- Parenteral Dosage Forms
- Improving solubility
- Reducing complexity of marketed products
- Reformulation
- Oral to parenteral conversion
- Improving physical/chemical stability
- Oral Dosage Forms
- Improving bioavailability/solubility
- Reformulation
- Parenteral to oral conversion
- Oral disintegration tablets
- Solutions
- Emulsions
- Improving physical/chemical stability